David Larsen

BTIG | Healthcare

David Larsen is an analyst from BTIG specializing in the Healthcare sector. Ranked #1661 out of 4771 analysts, they have issued 57 stock ratings with a success rate of 86.00% and an average return of 15.86%.

David Larsen has a well-established track record, with 57 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 86.00% and an average return of 15.86%, underscoring their expertise and ability to identify winning opportunities for investors.

#1661

Out of 4771

57

Total Ratings

+86.00%

Success Rate

+15.86%

Average Return

Recent Ratings Analysis

LFST

Aug 19, 2026

Target

$18.00

Current

$13.00

Performance

1.33%

David Larsen rated LFST as Buy on Aug 19, 2026, setting a price target of 18. Shares have remained stable near 13, leaving the 18 target still in play.

HSIC

Aug 19, 2026

Target

$110.00

Current

$87.30

Performance

-2.23%

On Aug 19, 2026, HSIC was given a Buy rating by David Larsen, with a target price of 110. The stock traded sideways with a -2.23% move, keeping the bullish thesis unresolved.

BTSG

Aug 03, 2026

Target

$90.00

Current

$57.88

Performance

-4.28%

BTSG received a Buy rating from David Larsen on Aug 03, 2026, aiming for 90. Price action was muted, as shares hovered around 57.88 despite the bullish outlook.

MDLN

Jul 31, 2026

Target

$55.00

Current

$32.39

Performance

-17.54%

On Jul 31, 2026, David Larsen published a Buy outlook on MDLN, with a target of 55. Market action contradicted the Buy thesis, as shares slipped to 32.39.

CYRX

Jul 24, 2026

Target

$25.00

Current

$15.27

Performance

-0.65%

David Larsen on Jul 24, 2026 assigned CYRX a Buy rating, with a price target of 25. The recommendation remains pending validation as shares consolidate around 15.27.

PGNY

Jul 24, 2026

Target

$40.00

Current

$27.08

Performance

-13.18%

On Jul 24, 2026, David Larsen reaffirmed PGNY with a Buy rating, targeting 40. Shares slid 13.18% despite the recommendation, highlighting downside risks.

HQY

Jul 24, 2026

Target

$115.00

Current

$94.55

Performance

-0.10%

HQY was rated Buy by David Larsen on Jul 24, 2026, with a price objective of 115. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

CCSI

Jul 24, 2026

Target

$45.00

Current

$36.26

Performance

-0.30%

On Jul 24, 2026, David Larsen initiated coverage on CCSI with a Buy rating and target of 45. Neutral price movement of -0.30% leaves room for interpretation.

OMDA

Jul 17, 2026

Target

$30.00

Current

$21.50

Performance

-9.28%

David Larsen issued a Buy recommendation for OMDA on Jul 17, 2026, price target set at 30. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

TOI

Jul 09, 2026

Target

$9.00

Current

$5.13

Performance

-12.31%

On Jul 09, 2026, TOI was evaluated by David Larsen, who gave a Buy rating and target of 9. Investors saw limited payoff as shares fell short of the 9 target.

VEEV

Jun 04, 2026

Target

$340.00

Current

$260.98

Performance

46.13%

David Larsen rated VEEV as Buy on Jun 04, 2026, setting a price target of 340. The call has proven timely, with shares rising 46.13% toward the price target of 340.

ASTH

Jun 02, 2026

Target

$50.00

Current

$38.03

Performance

—

On Jun 02, 2026, ASTH was given a Buy rating by David Larsen, with a target price of 50. The stock traded sideways with a % move, keeping the bullish thesis unresolved.

LFMD

May 04, 2026

Target

$10.00

Current

$3.03

Performance

-40.47%

LFMD received a Buy rating from David Larsen on May 04, 2026, aiming for 10. The rating hasn’t played out as hoped, with the stock trading 40.47% below expectations.

EVH

Feb 25, 2026

Target

$10.00

Current

$4.17

Performance

32.80%

On Feb 25, 2026, David Larsen published a Buy outlook on EVH, with a target of 10. Shares gained 32.80%, underscoring the accuracy of the bullish outlook toward 10.

HIMS

Feb 24, 2026

Target

—

Current

$27.44

Performance

77.49%

David Larsen on Feb 24, 2026 assigned HIMS a Neutral rating, with a price target of null. Shares outperformed expectations, climbing 77.49% despite the neutral view.

DOCS

Feb 06, 2026

Target

$50.00

Current

$24.71

Performance

-10.89%

On Feb 06, 2026, David Larsen reaffirmed DOCS with a Buy rating, targeting 50. Shares slid 10.89% despite the recommendation, highlighting downside risks.

SLP

Dec 18, 2025

Target

—

Current

$18.42

Performance

—

SLP was rated Neutral by David Larsen on Dec 18, 2025, with a price objective of null. Flat performance suggests the Hold view was reasonable.

PIII

Dec 12, 2025

Target

—

Current

$8.36

Performance

61.08%

On Dec 12, 2025, David Larsen initiated coverage on PIII with a Neutral rating and target of null. The Hold stance underestimated the stock’s strength as it gained 61.08%.

AGL

Dec 12, 2025

Target

—

Current

$92.60

Performance

415.16%

David Larsen issued a Neutral recommendation for AGL on Dec 12, 2025, price target set at null. A neutral call gave way to stronger-than-expected performance, closing in on null.

HCAT

Sep 05, 2025

Target

—

Current

$1.73

Performance

-48.82%

On Sep 05, 2025, HCAT was evaluated by David Larsen, who gave a Neutral rating and target of null. The Hold call avoided chasing into subsequent weakness of 48.82%.

DH

Sep 17, 2024

Target

$7.00

Current

$1.03

Performance

-78.27%

David Larsen rated DH as Buy on Sep 17, 2024, setting a price target of 7. The stock has underperformed, dropping 78.27% despite the bullish target of 7.

DCGO

May 09, 2024

Target

$7.00

Current

$0.37

Performance

-88.14%

On May 09, 2024, DCGO was given a Buy rating by David Larsen, with a target price of 7. Despite the Buy call, shares fell from 0.3652 to 0.3652, challenging the optimistic stance.

Frequency Asked Questions

Who is David Larsen?

David Larsen is an analyst from BTIG specializing in the Healthcare sector.

What is David Larsen's success rate?

David Larsen currently has a success rate of +86.00%.

How many ratings has David Larsen issued?

David Larsen has issued 57 stock ratings so far.

What is the average return of David Larsen's calls?

Their stock ratings have generated an average return of +15.86%.

What is David Larsen's ranking?

David Larsen is ranked #1661 out of 4771 analysts.

What types of ratings does David Larsen give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow David Larsen?

You can follow David Larsen by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by David Larsen?

Their latest rating was a Buy on LFST issued on 2026-08-19.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep